Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
193.91
+0.90 (0.47%)
At close: Aug 28, 2025, 4:00 PM
193.90
-0.01 (-0.01%)
After-hours: Aug 28, 2025, 4:31 PM EDT
Ascendis Pharma Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$239.88
Upside
+23.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $254 → $260 | Buy | Maintains | $254 → $260 | +34.08% | Aug 19, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $243 → $290 | Strong Buy | Maintains | $243 → $290 | +49.55% | Aug 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $210 → $230 | Buy | Maintains | $210 → $230 | +18.61% | Aug 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $212 → $220 | Buy | Maintains | $212 → $220 | +13.45% | Aug 8, 2025 |
| UBS | UBS | Strong Buy Maintains $306 → $307 | Strong Buy | Maintains | $306 → $307 | +58.32% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $203 | Buy | Maintains | $200 → $203 | +4.69% | Aug 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $289 → $295 | Buy | Maintains | $289 → $295 | +52.13% | Aug 8, 2025 |
| Stifel | Stifel | Strong Buy Maintains $212 → $254 | Strong Buy | Maintains | $212 → $254 | +30.99% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $245 → $254 | Buy | Maintains | $245 → $254 | +30.99% | Jul 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $213 → $243 | Strong Buy | Maintains | $213 → $243 | +25.32% | Jul 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $250 | Buy | Initiates | $250 | +28.93% | Jul 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $215 → $224 | Buy | Maintains | $215 → $224 | +15.52% | Jun 13, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $201 → $216 | Strong Buy | Maintains | $201 → $216 | +11.39% | Jun 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $196 → $201 | Strong Buy | Maintains | $196 → $201 | +3.66% | Jun 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +3.14% | May 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $180 → $250 | Hold → Buy | Upgrades | $180 → $250 | +28.93% | May 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.